Carpine and Relafen drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Carpine (pilocarpine hydrochloride) and Relafen (nabumetone). Common drug interactions include periorbital oedema among females and anaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Carpine and Relafen. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Carpine?

Carpine has active ingredients of pilocarpine hydrochloride. eHealthMe is studying from 5,561 Carpine users. Check the latest studies of Carpine.

What is Relafen?

Relafen has active ingredients of nabumetone. It is often used in arthritis. eHealthMe is studying from 6,243 Relafen users. Check the latest studies of Relafen.



On Jul, 21, 2026

19 people who take Carpine and Relafen together, and have interactions are studied.

Carpine and Relafen drug interactions.

What are the common drug interactions of Carpine and Relafen, by gender? *:

female:

  1. Periorbital oedema (swelling around the eyes)
  2. Pyogenic granuloma (small, raised, red bumps on the skin)
  3. Radiation injury (injuries are caused by radiation)
  4. Restless legs syndrome (a powerful urge to move your legs)
  5. Anxiety
  6. Pelvic fracture
  7. Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
  8. Delirium (wild excitement)
  9. Delusion (a false belief or opinion)
  10. Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))

male:

  1. Anaemia (lack of blood)
  2. Cellulitis (infection under the skin)
  3. Pyrexia (fever)
  4. Stomatitis (inflammation of mucous membrane of mouth)
  5. Thrombocytopenia (decrease of platelets in blood)
  6. Upper gastrointestinal haemorrhage (upper gastrointestinal bleeding)
  7. Drug maladministration
  8. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  9. Mouth haemorrhage (bleeding from mouth)
  10. Mucosal inflammation (infection of mucous membrane)

What are the common drug interactions of Carpine and Relafen, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  2. Asthenia (weakness)
  3. Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)
  4. Dry mouth
  5. Keratoconjunctivitis (inflammation of the cornea and conjunctiva)
  6. Myoclonic jerks (involuntary twitching of a muscle or group of muscles)
  7. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  8. Thinking abnormal

40-49:

n/a

50-59:

  1. Headache (pain in head)
  2. Hypoacusis (loss of hearing)
  3. Immunodeficiency
  4. Infection
  5. Liver tenderness (pain and discomfort in liver when touched)
  6. Malaise (a feeling of general discomfort or uneasiness)
  7. Mouth haemorrhage (bleeding from mouth)
  8. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  9. Neoplasm malignant (cancer tumour)
  10. Oedema peripheral (superficial swelling)

60+:

  1. Anxiety
  2. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  3. Pain in extremity
  4. Sinusitis (inflammation of sinus)
  5. Adjustment disorder
  6. Akathisia (a movement disorder characterized by a feeling of inner restlessness)
  7. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  8. Anaemia (lack of blood)
  9. Arthralgia (joint pain)
  10. Asthenia (weakness)

What are the existing conditions these people have? *

  1. Osteoporosis (bones weak and more likely to break): 7 people, 36.84%
  2. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 15.79%
  3. Urinary Tract Infection: 2 people, 10.53%
  4. Constipation: 2 people, 10.53%
  5. Essential Hypertension (primary hypertension): 2 people, 10.53%
  6. Insomnia (sleeplessness): 2 people, 10.53%
  7. Itching: 2 people, 10.53%
  8. Oesophageal Disorder (disease of oesophagus): 2 people, 10.53%
  9. Nausea And Vomiting: 2 people, 10.53%
  10. Paroxysmal Nocturnal Haemoglobinuria (haemoglobin in the urine): 2 people, 10.53%

* Approximation only. Some reports may have incomplete information.

Do you take Carpine and Relafen?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Carpine and Relafen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Carpine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Relafen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Carpine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Relafen and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on pilocarpine hydrochloride and nabumetone (the active ingredients of Carpine and Relafen, respectively), and Carpine and Relafen (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: